Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel
Clinical trial NCT04514419 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04514419
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2024-09-11
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.